Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Springfield › NPI 1942226006
Lab

System Coordinated Services, INC

System Coordinated Services, INC was paid $18.54M by Medicaid between Jan 2018 and Dec 2024, across 271 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 5.6% of everything it billed.

33Billing provider infoSYSTEM COORDINATED SERVICES, INC
SPRINGFIELD, MA 01104
33aNPI1942226006assigned 07/14/2006
33bProvider typeClinical Medical Laboratory
28Total paid$18.54M
24GClaims2,318,851
24DCodes billed271
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Massachusetts

Rank by total paid#5 of 63
Median peer was paid$473K
This provider vs. median39×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official HARRIS, JAMES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018345,704$2.88M
2019440,865$3.56M
2020340,600$3.10M
2021316,303$2.49M
2022292,887$2.21M
2023348,368$2.39M
2024incomplete234,124$1.90M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 5.6% 16,738 14,352 $1.03M
87590 5.2% 48,192 47,174 $963K
87490 4.4% 44,919 43,995 $816K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3.8% 39,958 38,173 $711K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 3.3% 29,896 29,602 $620K
84443 Thyroid stimulating hormone (TSH) 3.3% 72,776 68,128 $611K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.0% 136,485 118,006 $553K
80050 General health panel 3.0% 32,679 32,090 $548K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.8% 14,017 12,624 $526K
83036 Hemoglobin; glycosylated (A1C) 2.8% 100,033 96,004 $526K
86481 2.5% 6,953 6,768 $465K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2.4% 7,086 6,933 $450K
259 more codes
80053 Comprehensive metabolic panel 2.4% 123,816 $449K
80061 Lipid panel 2.4% 110,968 $442K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.8% 11,297 $338K
86803 1.6% 26,214 $299K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.6% 1,196 $291K
86780 1.5% 24,957 $273K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.5% 7,837 $270K
82607 1.4% 30,272 $254K
85027 1.3% 90,425 $248K
87086 Culture, bacterial; quantitative colony count, urine 1.3% 45,739 $239K
87660 1.3% 12,788 $233K
87510 1.3% 12,805 $233K
87480 1.3% 12,788 $232K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.2% 5,137 $232K
87634 1.2% 4,264 $228K
83013 1.2% 4,322 $218K
82728 1.1% 23,572 $213K
80048 Basic metabolic panel (calcium, ionized) 1.0% 95,516 $194K
87077 <1% 28,676 $172K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 7,408 $165K
87808 <1% 14,153 $160K
87340 <1% 19,080 $154K
87522 Neg quan hep c or qual rna <1% 4,358 $140K
83550 <1% 24,923 $136K
86003 <1% 3,062 $136K
82746 <1% 15,938 $130K
86706 <1% 15,058 $126K
86704 <1% 12,732 $119K
86480 <1% 2,174 $119K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 833 $119K
86708 <1% 12,136 $116K
83540 <1% 26,369 $105K
87536 <1% 2,284 $99K
84439 <1% 17,390 $95K
84403 <1% 4,299 $82K
84702 <1% 5,867 $80K
84153 <1% 6,883 $78K
87186 <1% 17,878 $78K
86762 <1% 6,051 $77K
86787 <1% 6,542 $75K
87147 <1% 8,295 $74K
82570 <1% 28,159 $73K
82043 <1% 25,922 $72K
ATP14 <1% 31,404 $71K
81001 <1% 38,876 $69K
87507 <1% 311 $69K
87150 <1% 2,266 $67K
87088 <1% 16,739 $65K
ATP08 <1% 36,689 $62K
83970 <1% 4,025 $62K
84146 <1% 3,853 $60K
86618 <1% 5,128 $59K
83880 <1% 4,799 $58K
86038 <1% 6,688 $57K
87070 <1% 8,138 $55K
86709 <1% 6,107 $53K
83735 <1% 16,788 $51K
83001 <1% 3,130 $48K
85610 <1% 39,097 $47K
86696 <1% 2,638 $44K
82784 <1% 7,023 $44K
84270 <1% 2,620 $44K
85651 <1% 17,944 $42K
87902 <1% 384 $40K
84481 <1% 3,653 $39K
87210 <1% 8,753 $37K
80076 <1% 12,071 $37K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,272 $36K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 486 $35K
83516 <1% 2,475 $34K
84425 <1% 2,469 $34K
82785 <1% 2,421 $31K
83002 <1% 1,920 $30K
86140 <1% 9,724 $30K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 46,696 $30K
86695 <1% 2,564 $29K
86765 <1% 2,558 $29K
86850 <1% 3,859 $28K
82533 <1% 2,418 $27K
36415 Collection of venous blood by venipuncture <1% 133,310 $27K
0240U <1% 185 $26K
87581 <1% 1,014 $26K
87486 <1% 1,015 $26K
83014 <1% 4,389 $26K
ATP17 <1% 13,056 $26K
84460 <1% 15,285 $25K
82652 <1% 813 $25K
82172 <1% 2,033 $25K
86735 <1% 2,093 $24K
82670 <1% 1,104 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 863 $22K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 862 $22K
83883 <1% 2,582 $22K
87081 <1% 3,593 $22K
84450 <1% 13,553 $22K
87209 <1% 1,634 $22K
86360 <1% 1,338 $22K
83010 <1% 2,806 $21K
82627 <1% 1,008 $20K
83690 <1% 4,379 $19K
82950 <1% 4,280 $19K
86430 <1% 4,507 $18K
ATP03 <1% 5,511 $18K
80164 <1% 4,685 $18K
86355 <1% 1,326 $17K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 50,669 $17K
86694 <1% 1,262 $16K
86235 <1% 495 $16K
86359 <1% 1,259 $16K
86376 <1% 1,431 $16K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 40 $15K
84550 <1% 6,683 $15K
86900 <1% 5,138 $14K
82565 <1% 9,622 $14K
85730 <1% 3,615 $14K
87517 <1% 516 $14K
82140 <1% 3,372 $14K
84255 <1% 899 $14K
84207 <1% 745 $14K
82465 <1% 2,967 $14K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 96 $14K
82105 <1% 1,446 $13K
85379 <1% 1,928 $12K
84703 <1% 1,909 $12K
87205 <1% 5,427 $12K
86665 <1% 452 $12K
84630 <1% 1,741 $12K
82150 <1% 2,895 $12K
86334 <1% 1,215 $12K
87338 <1% 1,111 $12K
87255 <1% 376 $11K
87177 <1% 1,712 $11K
82977 <1% 3,910 $11K
ATP15 <1% 3,664 $11K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 1,618 $11K
84165 <1% 2,148 $11K
82040 <1% 3,439 $10K
87046 <1% 1,236 $10K
87427 <1% 1,074 $10K
86200 <1% 993 $9K
83498 <1% 350 $9K
86769 <1% 296 $9K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 3,363 $9K
86800 <1% 738 $9K
86361 <1% 652 $8K
86364 <1% 1,073 $8K
82378 <1% 1,098 $8K
83615 <1% 3,412 $8K
82247 <1% 3,838 $8K
81025 <1% 1,248 $8K
86255 <1% 751 $8K
86160 <1% 521 $7K
83525 <1% 702 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 293 $7K
ATP02 <1% 2,385 $7K
83721 <1% 1,209 $7K
82550 <1% 3,524 $7K
83718 <1% 896 $7K
ATP11 <1% 3,635 $6K
82947 <1% 2,502 $6K
87040 <1% 1,195 $6K
84100 <1% 4,320 $6K
87045 <1% 958 $6K
84156 <1% 2,708 $6K
86664 <1% 408 $6K
83020 <1% 526 $6K
85045 <1% 2,632 $6K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 45 $6K
ATP13 <1% 1,462 $5K
83090 <1% 682 $5K
86039 <1% 644 $5K
86141 <1% 530 $5K
84520 <1% 5,173 $5K
80051 <1% 3,328 $5K
82248 <1% 2,856 $5K
84134 <1% 840 $5K
83520 <1% 350 $5K
80178 <1% 1,528 $5K
ATP07 <1% 1,827 $4K
87329 <1% 472 $4K
86300 <1% 418 $4K
85018 <1% 2,253 $4K
82310 <1% 2,389 $4K
82951 <1% 360 $4K
87324 <1% 682 $4K
30100 <1% 553 $4K
87449 <1% 683 $4K
86231 <1% 516 $4K
80069 <1% 2,054 $4K
87184 <1% 913 $3K
ATP18 <1% 1,173 $3K
84480 <1% 412 $3K
80177 <1% 573 $3K
85014 <1% 1,407 $3K
ATP05 <1% 631 $2K
30200 <1% 81 $2K
84484 <1% 441 $2K
86256 <1% 213 $2K
ATP10 <1% 1,080 $2K
84155 <1% 1,206 $2K
87106 <1% 256 $2K
87102 <1% 264 $2K
81015 <1% 824 $2K
86258 <1% 154 $2K
87015 <1% 354 $2K
84590 <1% 292 $2K
85660 <1% 263 $2K
82525 <1% 240 $1K
86592 <1% 433 $1K
86308 <1% 284 $1K
85048 <1% 2,383 $1K
83921 <1% 177 $1K
82952 <1% 351 $1K
87101 <1% 172 $1K
82668 <1% 140 $1K
86677 <1% 95 $1K
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) <1% 2,228 $1K
80185 <1% 379 $1K
ATP09 <1% 555 $1K
84075 <1% 554 $1K
84482 <1% 74 $1K
84436 <1% 394 $981.72
86606 <1% 61 $879.80
84132 <1% 407 $761.23
80156 <1% 141 $735.96
86705 <1% 83 $645.20
86381 <1% 63 $606.15
89055 <1% 196 $582.49
86663 <1% 52 $517.88
86001 <1% 28 $515.56
84152 <1% 65 $487.48
83519 <1% 37 $464.09
86609 <1% 15 $462.76
84478 <1% 165 $456.10
80162 <1% 188 $426.79
86666 <1% 21 $324.80
84144 <1% 14 $318.48
86593 <1% 82 $285.21
82239 <1% 17 $284.33
81338 <1% 117 $275.18
82103 <1% 38 $265.07
85613 <1% 12 $262.20
87220 <1% 80 $249.68
86147 <1% 12 $232.10
ATP04 <1% 94 $232.08
30000 <1% 99 $205.77
ATP06 <1% 190 $200.48
84681 <1% 12 $194.06
82232 <1% 25 $191.85
ATP16 <1% 49 $141.87
82330 <1% 14 $115.80
82553 <1% 26 $108.12
82955 <1% 12 $101.72
82270 <1% 23 $74.52
ATP12 <1% 21 $74.40
89051 <1% 12 $57.42
80175 <1% 13 $42.38
30600 <1% 49 $42.00
81050 <1% 16 $30.87

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARRIS, JAMES (REGIONAL DIRECTOR OF REIMBURSEMENT)
Same official

Other billing entities under HARRIS, JAMES

Full network →
ProviderLocationPaid
Saint Francis Hospital and Medical CenterHartford, CT$266.39M
Saint Mary's Hospital, INC.Waterbury, CT$163.27M
The Mercy Hospital INCSpringfield, MA$98.92M
Trinity Health of New England Provider Network Organization INCHartford, CT$41.97M
Riverbend Medical Group, INC.Springfield, MA$38.70M
Brightside INCSpringfield, MA$11.41M
The Mercy Hospital INCHolyoke, MA$10.93M
Mercy Inpatient Medical Associates INC.Springfield, MA$6.96M
State of New York Comptrollers OfficeBuffalo, NY$6.05M
Saint Francis Care Medical Group, PCHartford, CT$2.00M
Saint Francis Hospital and Medical CenterHartford, CT$1.42M
Pioneer Valley Cardiology Associates, INCSpringfield, MA$1.31M
Mercy Medical Group, INC.Springfield, MA$1.08M
Saint Francis Hospital and Medical CenterHartford, CT$382K
Prater Volunteer Rescue Squad INCGrundy, VA$331K
Diabetes and Lifestyle Management, LLCDerry, NH$273K
Mercy Specialist Physicians INCSpringfield, MA$101K
Health Access, INC.Clarksburg, WV$85K
Gibson County Podiatry LLCMilan, TN$83K
Saint Francis Hospital and Medical CenterHartford, CT$45K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.